BFRGHealthcare · Health Information ServicesTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 47 of 100 as at 4 Nov 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores BullFrog AI Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (99): Sales and profits are climbing, and climbing faster than before.
Value (6): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on BFRG, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 July 2021 | Bernstein | Upgrade | Market Perform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
BFRG appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, BullFrog AI Holdings, Inc. returned −51.7% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 83% of US stocks
Cheaper than 6% of US stocks
Cheaper than 56% of US stocks
Cheaper than 66% of US stocks
Higher than 98% of US stocks
Higher than 61% of US stocks
Higher than 7% of US stocks
Higher than 81% of US stocks
Higher than 11% of US stocks
Higher than 5% of US stocks
Higher than 99% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
BullFrog AI Holdings, Inc. has a market value of $9.8M and an enterprise value of $2.9M.
Revenue in the twelve months to 30 June 2026: $299K. The latest quarter grew 547.6% year on year.
Net income over the same four quarters: −$6.0M, a −2006.9% net margin.
Free cash flow in the twelve months to 30 June 2026: −$5.5M.
Trailing P/E: −0.9×; forward P/E: −3.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 51.96%, paying out 0% of earnings.
BullFrog AI Holdings, Inc. employs 9 people — $33K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own BullFrog AI Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
BullFrog AI announced that Founder and CEO Vin Singh will deliver the keynote at the AI Drug Discovery & Development Summit on October 27, 2026, at 5:30 p.m.
Why it matters — The announcement highlights the CEO’s participation in an event focused on AI drug discovery and development, areas relevant to BullFrog AI’s stated business.
BullFrog AI announced that CEO and founder Vin Singh will participate in the 20th Annual LD Micro Main Event, scheduled for October 19–21, 2026, in Los Angeles.
Why it matters — The announcement notes an upcoming event appearance by BullFrog AI’s CEO and founder.
BullFrog AI reported positive progress in its drug discovery program for a top-five global pharmaceutical company focused on major depressive disorder. It said the project reached key commercial milestones using its AI and machine-learning platform to identify and prioritize therapeutic targets.
Why it matters — The update highlights progress in a commercial drug-discovery project using BFRG’s proprietary platform.
Zacks Investment Research compares the year-to-date performance of Bullfrog AI Holdings Inc. (BFRG) and Agilent Technologies (A) against their sector. The article examines how each stock has fared relative to the broader medical/healthcare market so far this year.
Why it matters — BFRG watchers would care because the piece benchmarks the company's year-to-date performance against both a rival medical stock and the sector, offering context on how the firm is tracking relative to its peers.
BullFrog AI Holdings Inc. shares traded higher Wednesday morning after SEC filings revealed substantial open-market insider share purchases by both its Chief Executive Officer and Chief Financial Officer. The insider buying activity followed the regulatory disclosures.
Why it matters — BFRG watchers would care because substantial insider purchases by both the CEO and CFO may signal confidence in the company from its leadership.
As at 4 Nov 2026, BullFrog AI Holdings, Inc. ranks 47 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (99 of 100).
No analyst covering BullFrog AI Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BFRG are extrapolating price history, which says nothing about the business.
BullFrog AI Holdings, Inc. returned -51.7% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
BullFrog AI Holdings, Inc. is a digital biopharmaceutical company that applies artificial intelligence and machine learning to complex medical and healthcare data.
The most recent item we track (GlobeNewsWire, 27 Oct 2026): "BullFrog AI Founder and CEO Vin Singh to Deliver Keynote at AIDDD Summit". BullFrog AI announced that Founder and CEO Vin Singh will deliver the keynote at the AI Drug Discovery & Development Summit on October 27, 2026, at 5:30 p.m.
BullFrog AI Holdings, Inc. is a digital biopharmaceutical company that applies artificial intelligence and machine learning to complex medical and healthcare data. BullFrog AI Holdings, Inc. develops bfLEAP, an analytical platform designed to organize and analyze preclinical and clinical datasets for biotechnology, pharmaceutical, and other life sciences organizations. Its services support data-driven research workflows across drug discovery and development, with a focus on turning large, unstructured biomedical information into actionable insights. The company also works with external partners on AI-enabled analyses for medicine-related applications. Headquartered in Gaithersburg, Maryland, BullFrog AI Holdings, Inc. operates at the intersection of healthcare and technology, serving a specialized role in the growing market for AI-powered life sciences tools.
CEO Mr. Vininder Singh · 9 employees · United States · https://www.bullfrogai.com
